BugSeq

We're empowering microbiology labs to prevent and treat infections with nucleic acid sequencing.

[BugSeq @bugseq]

BugSeq leads clinical bioinformatics in consortium (@Ginkgo, @JumpcodeG , @planetinnovate , @TGenResearch , and more) developing end-to-end metagenomic solution for @EU_HaDEA.

See our announcement here: https://t.co/Ool9v1SHmF

[Ginkgo Bioworks @Ginkgo]

Today, we're thrilled to announce RANGER: RApid Next Generation Sequencing for Effective Medical Response, a consortium project supported by the @EU_HaDEA.

https://t.co/3Sg58dX5Fs

[BugSeq @bugseq]

Check out recent updates to the BugSeq platform in our latest blog post: Advancing Viral Surveillance, Sequencing Flexibility, AMR Prediction, and EPI2ME Integration

https://t.co/bBgSBzPbW0

[BugSeq @bugseq]

Discover how public health laboratories are integrating BugSeq into their everyday bioinformatics routines! Visit us at booth 200 at @APHL 2026; we are eager to learn about the challenges you face and discuss how our solutions can support your work. #APHL

[BugSeq @bugseq]

At #PASCV2026 ? Drop by the BugSeq booth (02T) to see how the most innovative labs are leveraging NGS to track viral outbreaks, antiviral resistance and more (and don’t forget to grab a notebook or bag)!

[BugSeq @bugseq]

⏰ 16:15-17:15 CEST
📍 #Bioinformatics Pipeline Corner, Arena 4
🗣️ Sam Chorlton, BugSeq CEO

See how we leverage interpretable AI to aid clinical translation and deliver industry-leading accuracy in:
🦠 Pathogen ID
💊 AMR prediction
📈 Outbreak analysis

#ESCMIDGlobal2026

[BugSeq @bugseq]

At #ESCMIDGlobal2026? Come visit booth H11 to learn more about how BugSeq can power your infectious disease bioinformatic workflows! From pathogen identification to AMR and outbreak analysis, BugSeq has a suite of analysis tools to power your NGS workflows.

[BugSeq @bugseq]

Interested in learning more about leveraging BugSeq’s suite of infectious disease bioinformatic workflows with your @nanopore sequence data? Check out the ONT Booth at #ESCMIDGlobal2026 for a live demonstration and more details (full schedule below): https://t.co/vJ2pqhrij9

[BugSeq @bugseq]

Did you know you can now submit data to BugSeq directly through the @nanopore EPI2ME platform? Submitting ONT sequence data to BugSeq is now easier than ever! Check out the blog post for more details on the integration between ONT and BugSeq: https://t.co/krcHavolgX

[BugSeq @bugseq]

The power of a curated database: BugSeq was most accurate for species identification in an independent evaluation of cloud-based platforms for microbial whole genome sequencing analysis. Read more: https://t.co/OA6bfmbzGx

[BugSeq @bugseq]

Miss the recent publication (https://t.co/ThmQviStqX) from @HopkinsMedicine leveraging BugSeq for infection control of C. auris? Stop by our booth at #SHEASpring2026 to learn how BugSeq powers genomic infection control programs.

[BugSeq @bugseq]

This program is supported by @GenomeCanada and @GenomeBC through the Genomic Applications Partnership Program. Learn more about the program in the announcement.

[BugSeq @bugseq]

BugSeq is delighted to partner with @UBC to improve detection, surveillance and early identification of emerging respiratory pathogens across Canada.

[GenomeBC @GenomeBC]

BC researchers are receiving $8M in federal funding to fast-track genomic solutions 🧬
8 teams will advance real-world projects, from pathogen detection to improved care for cancer, Type 1 diabetes and endometriosis.
Part of a $20M @GenomeCanada GAPP investment.

@BCCancer @SFU @UB @AbCelleraBio @ubcmsl

Find out more: https://t.co/RVKf82VgyQ

[BugSeq @bugseq]

Through this effort, the team will validate BugSeq’s bioinformatic platform to improve patient outcomes and strengthen Canadian biosecurity and pandemic preparedness.

[BugSeq @bugseq]

Hypervirulent Klebsiella pneumoniae is an emerging concern in clinical microbiology. Read how BugSeq was used to characterize the first cases of hypervirulent K. pneumoniae in Nebraska: https://t.co/iwIrsGuwRf

[BugSeq @bugseq]

In case you missed it, the recording of the BugSeq + @nanopore webinar is now available on demand! Discover how Dr. Georgios Kitsios used BugSeq for respiratory metagenomics in the @UPMC ICU:

https://t.co/Wi3LC7ghTk

[Oxford Nanopore @nanopore]

Seeing the full picture of infection, from ICU to surveillance, requires richer data, delivered faster. Join our webinar to learn how new approaches rapidly turn insight into action.

Join here: https://t.co/bjOUaVxiBn

[BugSeq @bugseq]

→ https://t.co/11YXZFXNnh

[BugSeq @bugseq]

Clinical interpretation and reporting of next-generation sequencing assays is challenging. Check out our recent blog post to learn about how BugSeq leverages machine learning and configurable thresholds to implement evidence-based reporting for your NGS assay.🧬

[BugSeq @bugseq]

Don't miss out! Join us on January 14th for an insightful webinar with Dr. Kitsios of @UPMC. Learn how BugSeq delivers rapid, actionable, and highly accurate results for respiratory #metagenomics in critical care settings.

https://t.co/faX1J80GWM

[BugSeq @bugseq]

2025 was an amazing year for sequencing in microbiology! Check out some of our favorite publications from the past year. 🦠

https://t.co/9DLVgrE1FY

[BugSeq @bugseq]

🚨 BugSeq now supports both EUCAST (new) and CLSI (already supported) breakpoints for the prediction of #AMR. This expansion ensures greater accuracy and global applicability in determining resistance. Get in touch for early access to EUCAST breakpoints on your account.

[BugSeq @bugseq]

Check out this recent article by Dr. Jose Alexander, @AdventHealth, on the power of BugSeq and how it is enabling NGS-based pathogen detection and resistance characterization in their healthcare system!

https://t.co/Dv1AQdM7rU

[BugSeq @bugseq]

At #AMPath2025? Here is one more reason why you need to drop by booth 447 to discuss bioinformatics with our team of experts!